Tardive Dyskinesia: Challenges in Screening, Diagnose and Treatment
Authors
Elmeida Effendy1, *
1Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
*Corresponding author.
Email: elmedia.effendi@usu.ac.id
Corresponding Author
Elmeida Effendy
Available Online 20 December 2024.
- DOI
- 10.2991/978-94-6463-616-1_5How to use a DOI?
- Abstract
The American Psychiatric Association defines Tardive Dyskinesia (TD) as involuntary athetoid or choreiform movements generally of the tongue, lower face, jaw and extremities (may involve the pharyngeal, diaphragmatic, or trunk muscles). Tardive dyskinesia is an iatrogenic condition that arises following extended use of antipsychotic and other dopamine-related medications. It is characterized by repetitive, involuntary muscle movements throughout the body.TD develops in association with the use of neuroleptic medication for at least a few months. Symptoms persist over 4-8 weeks.
- Copyright
- © 2024 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Elmeida Effendy PY - 2024 DA - 2024/12/20 TI - Tardive Dyskinesia: Challenges in Screening, Diagnose and Treatment BT - Proceedings of the 7th International Conference on Neuroscience, Neurology, and Psychiatry Universitas Sumatera Utara (ICONAP 2024) PB - Atlantis Press SP - 24 EP - 36 SN - 2468-5739 UR - https://doi.org/10.2991/978-94-6463-616-1_5 DO - 10.2991/978-94-6463-616-1_5 ID - Effendy2024 ER -